The effects of tannic acid on cytochrome P450 and phase II enzymes in mouse liver and kidney

Toxicology Letters

Volumn 143, Issue 2, 2003, Pages 209-216

  Krajka Kuźniak, Violetta ^a   Baer Dubowska, Wanda ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Cytochrome P450; Mouse liver and kidney microsomes; Phase II enzymes; Tannic acid

Indexed keywords

4 NITROPHENOL HYDROXYLASE; CYTOCHROME P450; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; METHOXYRESORUFIN DEMETHYLASE; PHENOL DERIVATIVE; QUINONE DERIVATIVE; QUINONE OXIDOREDUCTASE; RESORUFIN DERIVATIVE; TANNIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; FEMALE; KIDNEY; LIVER; MICROSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; WESTERN BLOTTING; XENOBIOTIC METABOLISM;

ANIMALIA; MURINAE; RODENTIA;

EID: 0038394282     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(03)00177-2     Document Type: Article

References (38)

1. Ahn D., Putt D., Kresty L., Stoner G.D., Fromm D., Hollenberg P.F. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis. 17:1996;821-828.
2. Athar M., Khan W.A., Mukhtar H. Effect of dietary tannic acid on epidermal lung, and forestomach polycyclic aromatic hydrocarbon metabolism and tumorigenicity in Sencar mice. Cancer Res. 49:1989;5784-5795.
3. Baer-Dubowska W., Gnojkowski J., Fenrych W. Effect of tannic acid on benzo[a]pyrene-DNA adduct formation in mouse epidermis: comparison with synthetic gallic acid esters. Nutr. Cancer. 29:1997;42-47.
4. Baer-Dubowska W., Szaefer H., Krajka-Kuźniak V. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds. Xenobiotica. 28:1998;735-743.
5. Baer-Dubowska W., Ignatowicz E., Balana B., Szaefer H. The effect of plant phenolics on the formation of 7,12-dimethylbenzαanthracene-DNA adducts and TPA stimulated polymorphonuclear neutrophils chemiluminescence in vitro. Proc. Am. Assoc. Cancer Res. 42:2001;20.
6. Begleiter A., Leith M.K., Curphey T.J., Doherty G.P. Induction of DT-diaphorase in cancer chemoprevention and chemotherapy. Oncol. Res. 9:1997;371-382.
7. Benson A.M., Barretto P.B., Stanley J.S. Induction of DT-diaphorase by anticarcinogenic sulfur compounds in mice. J. Natl. Cancer Inst. 76:1986;467-473.
8. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haparata T., Mayer R.T. Ethoxy-, penthoxy- and benzyloxy-phenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450. Biochem. Pharmacol. 34:1985;3337-3345.
9. Chen S.-C., Chung K.-T. Mutagenicity and antimutagenicity studies of tannic acid and its related compounds. Food Chem. Toxicol. 38:2000;1-5.
10. Chung K.-T., Wong T.Y., Wei C.-I., Huang Y.-W., Lin Y. Tannins and human health: a review. Crit. Rev. Food Sci. Nutr. 38:1998;421-464.
11. Das M., Mukhtar H., Bik D.P., Bickers D.R. Inhibition of epidermal xenobiotic metabolism in Sencar mice by naturally occurring plant phenols. Cancer Res. 47:1987;760-766.
12. De Flora S., Bennicelli C., Camoirano A., Serra D., Hochstein P. Influence of DT-diaphorase on the mutagenicity of organic and inorganic compounds. Carcinogenesis. 9:1988;611-617.
13. Gnojkowski J., Baer-Dubowska W., Klimek D., Chmiel J. Effect of toluidines on drug metabolizing enzymes in rat liver, kindey and lung. Toxicology. 32:1984;335-342.
14. Habig W.H., Pabst M.J., Jakoby W.B. Glutahione S-transferase. The first enzymatic steps in mercapturic acid formation. J. Biol. Chem. 249:1974;7130-7139.
15. Hursting S.D., Slaga T.J., Fischer S.M., DiGiovanni J., Phang J.M. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. 91:1999;215-225.
16. Jakoby W.B. Detoxication and drug metabolism: conjugation and related systems. Methods Enzymol. 77:1981;169-177.
17. Kitamura S., Terada A., Kamio H., Sugihara K., Koga N., Ohta S. DT-diaphorase-like quinone reductase in rat plasma. Biol. Pharm. Bull. 22:1999;883-885.
18. Koop D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 6:1992;724-730.
19. Krajka-Kuźniak V., Gnojkowski J., Baer-Dubowska W. Modulation of hepatic and renal GST by naturally occurring plant phenolics in rat and mouse. Johnson I.T., Fenwick G.R. Dietary Anticarcinogens and Antimutagens: Chemical and Biological Aspects. 2000;181-183 Royal Society of Chemistry, Cambridge.
20. Laemli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
21. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;230-265.
22. Mikstacka R., Gnojkowski J., Baer-Dubowska W. Effect of natural phenols on the catalytic activity of cytochrome P450 2E1. Acta Bioch. Pol. 49:2002;790-799.
23. Miyamoto K., Nomura M., Murayama T., Furukawa T., Hatano T., Yoshida T., Koshiura R., Okuda T. Antitumor activities of ellagotannins against sarcoma-180 in mice. Biol. Pharm. Bull. 16:1993;379-387.
24. Molle W.V., Berghe J.V., Brouckaert P., Libert C. Tumor necrosis factor-induced lethal hepatitis: pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH. FEBS Lett. 467:2000;201-205.
25. Mukhtar H., Das M., Khan W.A., Wang Z.Y., Bik D.P., Bickers D.R. Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a)anthracene-, benzo(a)pyrene-, 3-methylcholantrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res. 48:1988;2361-2365.
26. Nagao M., Sugimura T. Molecular biology of the carcinogen 4-nitroquinoline 1-oxide. Adv. Cancer Res. 23:1976;131-169.
27. Nepka C.h., Asprodini E., Kouretas D. Tannins, xenobiotic metabolism and cancer chemoprevention in experimental animals. Eur. J. Drug Metab. Pharmacokinet. 24:1999;183-189.
28. Newmark H.L. Plant phenolics as inhibitors of mutational and precarcinogenic events. Can. J. Physiol. Pharmacol. 65:1987;461-466.
29. Nijhoff W.A., Groen G.M., Peters W.H.M. Induction of rat hepatic and intestinal glutathione S-transfaerases and glutathione by dietary naturally occurring anticarcinogens. Int. J. Oncol. 3:1993;1131-1139.
30. Okey A.B., Riddick D.S., Harper P.A. Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15:1994;226-232.
31. Premdas P.D., Bowers R.J., Forkert P.-G. Inactivation of hepatic CYP2E1 by an epoxide of diallyl sulfone. J. Pharmacol. Exp. Ther. 293:2000;1112-1120.
32. Reinke L.A., Moyer M.J. p-Nitrophenol hydroxylation a microsomal oxidation which is highly inducible by ethanol. Drug Metab. Dispos. 13:1985;548-552.
33. Robbers J.E., Speedie M.K., Tyler V.E. Pharmacognosy and Pharmacobiotechnology. 1996;139-142 Williams & Wilkins, Baltimore.
34. Smitskamp-Wilms E., Hendriks H.R., Peters G.J. Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9. Gen. Pharmacol. 27:1996;421-429.
35. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
36. Winski S.L., Hargreaves R.H.J., Butler J., Ross D. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin. Cancer Res. 4:1998;3083-3088.
37. Yang C.S., Brady J.F., Hong J.-Y. Dietary effects on cytochromes P450, xenobiotics metabolism and toxicity. FASEB J. 6:1992;737-744.
38. Yang C.S., Smith T.J., Hong J.-Y. Cytochrome P450 enzymes as targets for chemoprevention against chemical carcinogenesis and toxicity: opportunities and limitations. Cancer Res. (Suppl.). 54:1994;1982s-1986s.